tirzepatide for menopause plus hormone therapy increases weight loss Postmenopausal women on the GLP-1

Wegovy is mainly prescribed for chronic weight management, while Ozempic is mainly prescribed for the management of type 2 diabetes mellitus

Get your custom peptide protocol: Tailored to your body and goals Precise dosing and cycle length Safe stacking combinations Backed by peer-reviewed studies Ready in under 2 minutes The Verdict: Retatrutide Wins on Trial Data, Zepbound Wins on Availability Retatrutide produced the largest average weight loss reported in a Phase 2 obesity trial to date, but it cannot be legally prescribed for weight loss as of June 2026

Enhances Insulin Sensitivity: GLP-1 improves insulin sensitivity, particularly in muscle tissue, allowing cells to utilize glucose more efficiently for energy rather than storing it as fat

Unlike patients in acute care settings, patients living in the community dont receive continuous monitoring